Old Web
English
Sign In
Acemap
>
Paper
>
TAK‐906, a Novel D 2 /D 3 Receptor Antagonist: First‐in‐Human Study of Single and Multiple Ascending Doses
TAK‐906, a Novel D 2 /D 3 Receptor Antagonist: First‐in‐Human Study of Single and Multiple Ascending Doses
2020
Roger L. Whiting
Borje Darpo
Chunlin Chen
Randall Stoltz
Keywords:
Human study
Diabetes mellitus
Biology
Receptor antagonist
Endocrinology
Internal medicine
first in human
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]